Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Urologists Examine Role of Pollutants, Medications and Testosterone on Men's Health
NEW ORLEANS, May 14, 2022 /PRNewswire/ — Does environmental exposure impact men's fertility? How does testosterone impact bone density loss and personal budgets? Can a lower dose of urinary medication decrease the risk of a major cardiac event?
Researchers will be presenting these men's health study findings at the 117th Annual Scientific Meeting of the American Urological Association. R. Charles Welliver, Jr., MD, associate professor of surgery in the Department of Urology at Albany Medical College, will moderate a press session featuring the following four abstracts at the Ernest N. Morial Convention Center in New Orleans on May 14, 2022, at 10 a.m. CT.
Federico Belladelli, MD, from the San Raffaele Hospital, investigated the association between air pollutants and semen levels in men seeking medical treatments for infertility. Does Air Pollution Impact on Semen Parameters: Findings From a Real-Life Cross-Sectional Study in White-European Infertile Men
Ruben Blachman-Braun, MD, of the University of Miami Miller School of Medicine, evaluated if men receiving phosphodiesterase type 5 inhibitors for lower urinary tract symptoms have a decreased risk of major adverse cardiac events or venous thromboembolism. Is Tadalafil Associated with Decreased Risk of Major Adverse Cardiac Events or Venous Thromboembolism in Men with Lower Urinary Tract Symptoms?
The cost of undergoing treatment with testosterone therapy via direct-to-consumer platforms was compared to the cost for similar care at a tertiary center by Nicholas Sellke, MD, of Case Western Reserve University. Cost Analysis of Direct-to-Consumer Telehealth Platforms Offering Testosterone Therapy
Factors such as age, diabetes and obstructive sleep apnea were researched by Jose Flores, MD, of Memorial Sloan Kettering Cancer Center, as significant predictors of bone density loss. Analyzing the Impact of Testosterone on Bone Density Loss
"The AUA and the Annual Meeting continue an important focus on topics in men's health," said Dr. Welliver. "The research emphasized here encompasses the breadth of men's health with important topics like medication safety, fertility effects of environmental exposures and the effects of testosterone both on bone health and on men's wallets. The AUA is an important champion for issues regarding men's health and these presentations highlight some of the best work at our meeting."
About the American Urological Association: The 117th Annual Meeting of the American Urological Association takes place May 13-16 at the Ernest N. Morial Convention Center in New Orleans. Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology and has nearly 24,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.
Media Contact:
Caitlin Lukacs, Corporate Communications and Media Relations Manager
410-689-4081, clukacs@auanet.org
SOURCE American Urological Association